[STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. II. ON VARIOUS DISEASES EXCEPT ARTERIOSCLEROSIS].
D000933:Antifibrinolytic Agents; D001161:Arteriosclerosis; D002286:Carcinoma, Ehrlich Tumor; D002318:Cardiovascular Diseases; D003095:Collagen Diseases; D003141:Communicable Diseases; D004704:Endocrinology; D004791:Enzyme Inhibitors; D005341:Fibrinolysin; D005762:Gastroenterology; D006405:Hematology; D006801:Humans; D007674:Kidney Diseases; D008659:Metabolic Diseases; D008660:Metabolism; D051379:Mice; D009369:Neoplasms; D012106:Research; D013927:Thrombosis; D014357:Trypsin; D014361:Trypsin Inhibitors; D000979:alpha-2-Antiplasmin
D000933:Antifibrinolytic Agents; D004791:Enzyme Inhibitors; D014361:Trypsin Inhibitors; D000979:alpha-2-Antiplasmin; D014357:Trypsin; D005341:Fibrinolysin
CARCINOMA, EHRLICH TUMOR; CARDIOVASCULAR DISEASES; COLLAGEN DISEASES; COMMUNICABLE DISEASES; ENDOCRINOLOGY; ENZYME INHIBITORS; EXPERIMENTAL LAB STUDY; FIBRINOLYSIN; GASTROENTEROLOGY; HEMATOLOGY; KIDNEY DISEASES; METABOLIC DISEASES; METABOLISM; MICE; NEOPLASMS; THROMBOSIS; TRYPSIN